A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer (Q34034042)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer |
scientific article |
Statements
1 reference
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer (English)
1 reference
Jordan Berlin
1 reference
Johanna C Bendell
1 reference
Lowell L Hart
1 reference
Irfan Firdaus
1 reference
Ira Gore
1 reference
Robert C Hermann
1 reference
Mary F Mulcahy
1 reference
Mark M Zalupski
1 reference
Howard M Mackey
1 reference
Robert L Yauch
1 reference
Richard A Graham
1 reference
Gordon L Bray
1 reference
Jennifer A Low
1 reference
18 October 2012
1 reference
1 reference
19
1 reference
258-267
1 reference
Identifiers
1 reference
1 reference